Patents by Inventor Torsten Klockenbring

Torsten Klockenbring has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-plasmodium parasite antibodies
    Patent number: 10577412
    Abstract: The technology provided herein relates to novel human antibodies against Plasmodium parasites, in particular against the malaria parasite Plasmodium falciparum. The present disclosure pertains to antibodies against apical membrane antigen 1 (AMA-1). These antibodies have high affinity e.g. to Plasmodium falciparum schizonts and merozoites, inhibit the reinvasion of merozoites into erythrocytes and thereby neutralize parasitic multiplication.
    Type: Grant
    Filed: April 11, 2016
    Date of Patent: March 3, 2020
    Assignee: FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
    Inventors: Rolf Fendel, Stefan Barth, Rainer Fischer, Andreas Reimann, Dominika Maskus, Torsten Klockenbring
  • ANTI-PLASMODIUM PARASITE ANTIBODIES
    Publication number: 20180086823
    Abstract: The technology provided herein relates to novel human antibodies against Plasmodium parasites, in particular against the malaria parasite Plasmodium falciparum. The present disclosure pertains to antibodies against apical membrane antigen 1 (AMA-1). These antibodies have high affinity e.g. to Plasmodium falciparum schizonts and merozoites, inhibit the reinvasion of merozoites into erythrocytes and thereby neutralize parasitic multiplication.
    Type: Application
    Filed: April 11, 2016
    Publication date: March 29, 2018
    Inventors: Rolf Fendel, Stefan Barth, Rainer Fischer, Andreas Reimann, Dominika Maskus, Torsten Klockenbring
  • Anti-plasmodium parasite antibodies
    Patent number: 9611318
    Abstract: The technology provided herein relates to novel human antibodies against Plasmodium parasites, in particular against the malaria parasite Plasmodium falciparum. The present disclosure pertains to antibodies against merozoite surface protein 10 (MSP10). These antibodies have high affinity e.g. to Plasmodium falciparum schizonts and merozoites, inhibit the reinvasion of merozoites into erythrocytes and thereby neutralize parasitic multiplication.
    Type: Grant
    Filed: July 31, 2013
    Date of Patent: April 4, 2017
    Assignee: FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
    Inventors: Rolf Fendel, Torsten Klockenbring, Stefan Barth, Stephanie Kapelski, Dominika Maskus, Rainer Fischer, Andreas Reimann
  • NOVEL ANTI-PLASMODIUM PARASITE ANTIBODIES
    Publication number: 20150197562
    Abstract: The technology provided herein relates to novel human antibodies against Plasmodium parasites, in particular against the malaria parasite Plasmodium falciparum. The present disclosure pertains to antibodies against merozoite surface protein 10 (MSP10). These antibodies have high affinity e.g. to Plasmodium falciparum schizonts and merozoites, inhibit the reinvasion of merozoites into erythrocytes and thereby neutralize parasitic multiplication.
    Type: Application
    Filed: July 31, 2013
    Publication date: July 16, 2015
    Inventors: Rolf Fendel, Torsten Klockenbring, Stefan Barth, Stephanie Kapelski, Dominika Maskus, Rainer Fischer, Andreas Reimann
  • Isolation of allergen-specific immunoglobulin genes from human B-cells from atopy sufferers
    Patent number: 8399200
    Abstract: A process is disclosed which enables the establishing of comprehensive immunoglobulin-specific reaction profiles of subjects with disorders of the immune function by the individual V gene repertoire of Ig-expressing B cells. The process comprises the isolation of B cells from body fluids, the isolation of individual B cells and their genetic material, the amplification of nucleic acids coding the variable regions of an antibody expressed by a B cell, the recombinant preparation of antibodies by expressing the amplificates, and the determination of the binding capability of the recombinant antibody to antigens.
    Type: Grant
    Filed: May 25, 2005
    Date of Patent: March 19, 2013
    Assignee: Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
    Inventors: Gernot Achatz, Michael Huhn, Rainer Fischer, Fatima Ferreira, Elke Luger, Michael Stöcker, Stefan Barth, Torsten Klockenbring
  • Isolation Of Allergen-Specific Immunoglobulin Genes From Human B-Cells From Atopy Sufferers
    Publication number: 20100035241
    Abstract: A process is disclosed which enables the establishing of comprehensive immunoglobulin-specific reaction profiles of subjects with disorders of the immune function by the individual V gene repertoire of Ig-expressing B cells.
    Type: Application
    Filed: May 25, 2005
    Publication date: February 11, 2010
    Inventors: Gernot Achatz, Michael Huhn, Rainer Fischer, Fatima Ferreira, Elke Luger, Michael Stöcker, Stefan Barth, Torsten Klockenbring